(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one
Structure Info
- Chemspace ID
- CSSB00000053630 (In-Stock Building Blocks)
- CAS
- 33419-42-0, 120068-37-3
- MFCD
- MFCD00869325, MFCD26955140
- IUPAC Name
- (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one
- Mol formula
- C29H32O13
- Mol weight
- 589 Da
- Catalog Number(s)
- 12092, 28435, 036530, 41049, 109763, 146668, 301233, A174646, AA003A03, AB011824, AB52831, ACM33419420, ACUKNF325, AG003A2V, AGN-PC-0R8Y9U, AKOS007930275, AP33419420-A, AR003ARV, AS-35312, AY126852, ArZ-UP355537, ArZ-UP479820, B2703-001509, BB4LS-EN300-97099, BBLS00000053630, BBP03964, BD33259, BE164434, BIFK0021, CB24942, CFN89061, CSC000053630, CT1491, E768, E933750, EBC-11154, EN300-97099, HY-13629, HY-13629R, J20643, J90059, LAN-B42204, LN01327181, M14134, ME09941, NP4193, S1225, SC-12127, ST003BJN, T0132, TX003B8J, W-60382, Z1304065033, ZX-CY001596, bbls00000053630
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.16
- Heavy atoms count
- 42
- Rotatable bond count
- 5
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.551
- Polar surface area (Å)
- 161
- Hydrogen bond acceptors count
- 12
- Hydrogen bond donors count
- 3
![Chemical structure of (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one (C29H32O13) - CSSB00000053630](/st/structure/200/42fa3ac1fe92668431110df417aef2f8/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529%255BC%2540H%255D%2528O%255BC%2540%2540H%255D2O%255BC%2540%2540H%255D3CO%255BC%2540%2540H%255D%2528C%2529O%255BC%2540H%255D3%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png "C29H32O13")
- Zoom the structure
- CSSB00000053630
Items Overall 104 items from 24 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 100 mg | 20.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 1 g | 35.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 5 g | 140.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 25 g | 560.00 | |
Description: Name:(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 100 mg | 20.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 250 mg | 26.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 1 g | 35.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 5 g | 140.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 25 g | 560.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 98 | 100 g | 1,792.00 | |
Description: Name:(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 250 mg | 26.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 1 g | 35.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 5 g | 140.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 25 g | 560.00 | |
Description: Name:(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 16.86 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 22.00 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 24.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 24.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 25.00 | |
| 1st Scientific CN | 3 days | China To: | 98 | 1 mg | 8.80 | |
| 1st Scientific CN | 3 days | China To: | 98 | 250 mg | 20.90 | |
| 1st Scientific CN | 3 days | China To: | 98 | 1 g | 28.60 | |
| 1st Scientific CN | 3 days | China To: | 98 | 5 g | 113.30 | |
| 1st Scientific CN | 3 days | China To: | 98 | 25 g | 449.90 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Hazard statement: 6.1; CAS: 33419-42-0 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 8.80 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 250 mg | 20.90 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 g | 28.60 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 g | 113.30 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 25 g | 449.90 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Hazard statement: 6.1; CAS: 33419-42-0 | ||||||
| Matrix Scientific | 3 days | United States To: | 98 | 5 g | 139.70 | |
| Matrix Scientific | 3 days | United States To: | 98 | 25 g | 568.70 | |
Description: Name: (5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 21.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 23.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 24.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 25.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 28.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 55.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 21.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 23.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 24.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 25.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 28.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 55.00 | |
| AboundChem | 5 days | United States To: | 98 | 1 g | 39.60 | |
| AboundChem | 5 days | United States To: | 98 | 5 g | 154.00 | |
Description: Name: Etoposide; CAS: 33419-42-0 | ||||||
| AiFChem | 5 days | United States To: | 98 | 5 g | 129.00 | |
| AiFChem | 5 days | United States To: | 98 | 25 g | 519.00 | |
Description: (5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 16.86 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 22.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 24.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 24.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 25.00 | |
| Oakwood Products, Inc. | 7 days | United States To: | 97 | 25 mg | 47.30 | |
Description: Name: Demethylepipodophyllotoxin-beta-D-ethylideneglucoside Purity:97%; CAS: 33419-42-0 | ||||||
| Angene US | 10 days | United States To: | 98 | 100 mg | 31.50 | |
| Angene US | 10 days | United States To: | 98 | 25 g | 638.10 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; CAS: 33419-42-0 | ||||||
| Apollo Scientific | 10 days | United Kingdom To: | 90 | 50 mg | 49.00 | |
| Apollo Scientific | 10 days | United Kingdom To: | 90 | 100 mg | 69.00 | |
| Apollo Scientific | 10 days | United Kingdom To: | 90 | 500 mg | 145.00 | |
Description: CAS: 33419-42-0 | ||||||
| AiFChem CN | 10 days | China To: | 98 | 100 g | 1,729.00 | |
Description: (5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 25 mg | 4.60 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 mg | 6.90 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 250 mg | 9.20 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 1 g | 32.20 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 5 g | 134.55 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 25 g | 612.95 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 g | 1,961.90 | |
| Ambeed CN | 12 days | China To: | 98 | 1 mg | 9.00 | |
| Ambeed CN | 12 days | China To: | 98 | 250 mg | 23.40 | |
| Ambeed CN | 12 days | China To: | 98 | 1 g | 31.50 | |
| Ambeed CN | 12 days | China To: | 98 | 5 g | 126.00 | |
| Ambeed CN | 12 days | China To: | 98 | 25 g | 504.00 | |
| Ambeed CN | 12 days | China To: | 98 | 100 g | 1,612.80 | |
Description: Name: Etoposide; CAS: 33419-42-0 | ||||||
| Ambeed GmbH | 12 days | Germany To: | 98 | 1 mg | 9.00 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 250 mg | 23.40 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 1 g | 31.50 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 5 g | 126.00 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 25 g | 504.00 | |
Description: Name: Etoposide; CAS: 33419-42-0 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 98 | 1 mg | 9.00 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 250 mg | 23.40 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 1 g | 31.50 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 5 g | 126.00 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 25 g | 504.00 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 100 g | 1,612.80 | |
Description: Name: Etoposide; CAS: 33419-42-0 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 9.90 | |
| AA BLOCKS | 12 days | United States To: | 98 | 100 mg | 12.10 | |
| AA BLOCKS | 12 days | United States To: | 98 | 250 mg | 23.10 | |
| AA BLOCKS | 12 days | United States To: | 98 | 1 g | 34.10 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 g | 135.30 | |
| AA BLOCKS | 12 days | United States To: | 98 | 25 g | 541.20 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; CAS: 33419-42-0 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 11.50 | |
| A2B Chem | 12 days | United States To: | 98 | 100 mg | 12.65 | |
| A2B Chem | 12 days | United States To: | 98 | 250 mg | 21.85 | |
| A2B Chem | 12 days | United States To: | 98 | 500 mg | 32.20 | |
| A2B Chem | 12 days | United States To: | 98 | 1 g | 40.25 | |
| A2B Chem | 12 days | United States To: | 98 | 5 g | 152.95 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; CAS: 33419-42-0 | ||||||
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 100 mg | 20.00 | |
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 250 mg | 26.00 | |
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 1 g | 35.00 | |
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 5 g | 140.00 | |
Description: Name:(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; CAS: 33419-42-0 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 8.80 | |
| 10X CHEM | TBD | United States To: | 98 | 250 mg | 22.00 | |
| 10X CHEM | TBD | United States To: | 98 | 1 g | 28.60 | |
| 10X CHEM | TBD | United States To: | 98 | 5 g | 113.30 | |
| 10X CHEM | TBD | United States To: | 98 | 25 g | 452.10 | |
Description: (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Hazard statement: 6.1; CAS: 33419-42-0 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(thiophen-2-yl)-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB00116206870](/st/structure/200/d60e24062df5773e1e4773f7749613dd/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529%255BC%2540H%255D%2528O%255BC%2540%2540H%255D2O%255BC%2540%2540H%255D3CO%255BC%2540H%255D%2528O%255BC%2540H%255D3%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC%253DCS2%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of {4-[(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenoxy}phosphonic acid - CSSB00000053714](/st/structure/200/48bc3cbb5c026b193c49f5f2892737ec/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OP%2528O%2529%2528O%2529%253DO%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529%255BC%2540H%255D%2528O%255BC%2540%2540H%255D2O%255BC%2540%2540H%255D3CO%255BC%2540%2540H%255D%2528C%2529O%255BC%2540H%255D3%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
Similarity Analogs
![Chemical structure of 16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB00121573923](/st/structure/200/11d429c5ca85b26fbb6bcd30f2cf7954/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529C1C2C%2528COC2%253DO%2529C%2528OC2OC3COC%2528C%2529OC3C%2528O%2529C2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of 16-{[(4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB02531767576](/st/structure/200/2181e3819b5c47f061f9d9bf60df5fc2/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529C1C2C%2528COC2%253DO%2529C%2528O%255BC%2540%2540H%255D2O%255BC%2540%2540H%255D3COC%2528C%2529O%255BC%2540H%255D3%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of (10R,11R)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(3,5-dimethoxy-4-methylphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB03436546921](/st/structure/200/8b81dcd1b0cdd447e90722a9a95f86a1/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1C%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2C%2528COC2%253DO%2529C%2528O%255BC%2540%2540H%255D2O%255BC%2540%2540H%255D3CO%255BC%2540%2540H%255D%2528C%2529O%255BC%2540H%255D3%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of {4-[16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenoxy}phosphonic acid - CSSB02125556013](/st/structure/200/79704e53394a050cd32eb9852b048558/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OP%2528O%2529%2528O%2529%253DO%2529C1C2C%2528COC2%253DO%2529C%2528OC2OC3COC%2528C%2529OC3C%2528O%2529C2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of {4-[(10R,11R,15R,16S)-16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenoxy}phosphonic acid - CSSB21193440958](/st/structure/200/390c9a790683cfc0a907739ae1191c1e/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OP%2528O%2529%2528O%2529%253DO%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529%255BC%2540H%255D%2528OC2OC3COC%2528C%2529OC3C%2528O%2529C2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
![Chemical structure of (10R,11R,15R,16S)-10-(4-hydroxy-3,5-dimethoxyphenyl)-16-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB00102607287](/st/structure/200/e07e0cef0fc2a8e2a73e6bf495da8ee9/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529%255BC%2540H%255D%2528O%255BC%2540%2540H%255D2O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C2%253DCC3%253DC%2528OCO3%2529C%253DC12.png)
